Your Article Summary
See Latest ArticlesEnteric Coating of Mycophenolate Reduces Dosage Adjustments
Transplantation Proceedings, 07/02/09
Brister K et al. - Mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS) are bioequivalent. However, the effectiveness of MMF may be limited by gastrointestinal (GI) side effects. Patients receiving MMF required more immunosuppressive medication adjustments, which may complicate care and decrease overall compliance.
Related Articles
A prospective open-label study of mycophenolate mofetil for the treatment of diffuse systemic sclerosis
Rheumatology, 10/23/09
Relevance Score: 85%
A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids
Liver Transplantation, 11/03/09
Relevance Score: 84%
Severe acute fibrinous and organizing pneumonia (AFOP) causing ventilatory failure: Successful treatment with mycophenolate mofetil and corticosteroids
Respiratory Medicine, 10/14/09
Relevance Score: 84%
Mycophenolate mofetil and intravenous cyclophosphamide are similar as induction therapy for class V lupus nephritis
Kidney International, 11/05/09
Relevance Score: 83%
Safety and Tolerance of Sodium Mycophenolate in Patients After Renal Transplantation--An Observational Study
Transplantation Proceedings, 11/05/09
Relevance Score: 83%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes and Cardiovascular Disease During Androgen Deprivation Therapy: Observational Study of Veterans With Prostate Cancer
Journal of the National Cancer Institute, 12/09/09
Combined Resistance and Aerobic Exercise Program Reverses Muscle Loss in Men Undergoing Androgen Suppression Therapy for Prostate Cancer Without Bone Metastases: A Randomized Controlled Trial
Journal of Clinical Oncology, 12/09/09
Efficacy of venlafaxine, medroxyprogesterone acetate, and cyproterone acetate for the treatment of vasomotor hot flushes in men taking gonadotropin-releasing hormone analogues for prostate cancer: A double-blind, randomised trial
The Lancet Oncology - Online First, 12/09/09
Today in Transplantation...keeping you current
Receive free subspecialty "5-minute updates" via email
Successful DCD Kidney Transplantation Using Early Corticosteroid Withdrawal
American Journal of Transplantation, 12/09/09
Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation
Pediatric Nephrology, 12/09/09
Calculated PRA (CPRA): The New Measure of Sensitization for Transplant Candidates
American Journal of Transplantation, 12/09/09